New Study: Adult Stem Cells Reverse Progressive MS-like Disease

  • New Study: Adult Stem Cells Reverse Progressive MS-like Disease

    Gives Patients New Chance at Life Pain and Drug Free A new study published in the journal Neurology found that adult stem cells were successful in treating and reversing neuromyelitis optica, a debilitating autoimmune disease similar to multiple sclerosis (MS). This is yet another medical breakthrough for adult stem cells, as opposed to embryonic stem cells, which […]

  • Wiser Investment: Non-Embryonic Stem Cells Receive Millions from Maryland Fund

    The state of Maryland is home to the Johns Hopkins University School of Medicine, one of the country’s leading stem cell research programs.   Maryland is also one of a handful of states to provide public funds for stem cell research, through its Maryland Stem Cell Research Fund (MSCRF).  The MSCRF first started distributing grants […]

  • Video: Once Quadriplegic, Woman Celebrates Lasting Improvement from Adult Stem Cells

    Today the Charlotte Lozier Institute releases its ninth Stem Cell Research Facts video, which revisits the life of adult stem cell recipient Laura Dominguez-Tauer. Her story is a testament to hope, inspiration, and what can happen when the best modern medicine meets unwavering human resilience.   When Laura was only 16, a devastating car crash left […]

  • Adult Stem Cells and Gene Therapy Save a Young Boy

    When people talk about something that “saved their skin,” they usually mean that it helped them out of a difficult situation. But a young boy in Germany has literally had his skin—and his life—saved through the use of genetically-engineered adult stem cells. The boy suffered from a condition called junctional epidermolysis bullosa, a severe and […]

  • Dr. David Prentice: “What’s All the Fuss About Stem Cells?”

    What are stem cells and why are they so fraught with both hope and controversy? CLI’s Vice President and Research Director, Dr. David Prentice, recently joined Molly Smith, host of From the Median, to explain the science, history, and politics of stem cells — click to listen!     Click to view the original post at From […]

  • Near Absence of Embryonic Stem Cells in California Clinical Trial Program

    In 2013, the California Institute for Regenerative Medicine (CIRM) – the nation’s largest funder of stem cell research outside of the federal government – authorized a new program, the Alpha Stem Cell Clinics Network.

    The Network’s goal, according to CIRM, “is to accelerate the development and delivery of stem cell treatments to patients.”  To achieve this, CIRM approved $70 million “to create a new statewide network of sites that will act as a hub for stem cell clinical trials.”  CIRM envisioned a network of “up to five clinic sites at established academic institutions.”  To date, three Alpha Stem Cell Clinics have been created, housed at City of Hope, University of California San Diego, and UCLA/UC Irvine.

  • The Continuing Promise of Non-Embryonic Stem Cells

    The California based City of Hope, one of the country’s leading cancer research hospitals, recently sent out birthday greetings to the California Institute for Regenerative Medicine (CIRM), the nation’s leading funder — apart from the federal government – of stem cell research.

    “On its 10th birthday, the California Institute for Regenerative Medicine celebrated 10 stem cell therapies that have been approved for clinical trials, including an HIV/AIDS trial at City of Hope,” the message read.

    The birthday greeting contained an unintended irony, for while CIRM was approved by California voters a decade ago to give priority funding to human embryonic stem cell research, eight of the 10 approved clinical trials referenced by City of Hope were for research projects using adult and other non-embryonic stem cells.

  • Ethical Stem Cells Provide Model for Progress in Down Syndrome Research

    Researchers using ethically uncontroversial induced pluripotent stem cells (iPSCs) have achieved what appears to be a major breakthrough in understanding the origin and development of Down syndrome, according to a new study recently published in Nature Communications.

  • Ethical Stem Cells: Back to Basics

    This report looks at the continuing pattern of stem cells research funding and finds that grants continue to be given to projects that show the most promise – namely ethical stem cell research.

  • Adult Stem Cells Imitate Human Brain, Are Hope for Neurological Disorders

    A study published last week has shown that ethical adult stem cells can be used to create three-dimensional living tissues that imitate the developing human brain.  In their findings, published in the science journal Nature, researchers asserted that, by using human stem cells derived from skin cells, they were able to assemble brain-like pieces of […]

  • Video: Multiple Sclerosis Survivor Thriving Six Years after Adult Stem Cell Transplant

    May 30 marked World Multiple Sclerosis Day, a day to bring together the global MS community, raise awareness, and share stories. In a new patient video released by the Charlotte Lozier Institute’s Stem Cell Research Facts project, multiple sclerosis survivor Allison Carr shares about her journey of thriving and encouraging others six years after her […]

  • Trends Show More Federal Funds Awarded to Non-Embryonic Stem Cell Research

    Soon after then-President Clinton’s National Bioethics Advisory Committee (NBAC) in 1999 issued a report recommending federal funding for human embryonic stem cell research (hESCR) the subject of such funding became one of the nation’s most hotly contested public policy issues. It was the subject of President George W. Bush’s first nationally televised address, and in […]

  • Video: “Stunning” Recovery of Woman from Stroke after Adult Stem Cell Transplant

    Today the Charlotte Lozier Institute releases its eighth Stem Cell Research Facts video, which tells the story of Sonia Coontz’s “miracle” stroke recovery thanks to an adult stem cell transplant at Stanford University.   Sonia, a 31-year-old Californian, suffered a stroke in 2011. Without any warning, she found herself unable to move her right arm […]

  • Fact Sheet: Adult Stem Cell Research and Transplants

    Adult stem cell transplants are already widely used to the benefit of over a million people. Well over 1 million patients worldwide have been treated with adult stem cells and experienced improved health, based on data gathered by December 2012.

  • Video: Dr. Joel McGuirk and the Adult Stem Cell Revolution

    Today the Charlotte Lozier Institute releases its sixth in its series of Stem Cell Research Facts videos. This story features the work of Dr. Joseph McGuirk, an adult stem cell expert at the University of Kansas Hospital, and tells the story of Chance Runnion’s recovery from leukemia after an adult stem cell transplant.

  • Baby

    Grants for Stem Cell Research Favor Ethical Approaches

    The Maryland Stem Cell Research Fund (MSCRF) has awarded two rounds of grants since the Charlotte Lozier Institute last analyzed the Fund’s pattern of grant making for stem cell research, in the fall of 2013. That study found that since MSCRF first began awarding grants in 2007, its pattern of giving shifted over the years from strongly favoring projects focusing on ethically contentious human embryonic stem cell research (hESCR) to projects focusing on ethically non-contentious adult stem cells and other non-embryonic stem cell research.

  • California Stem Cell Clinical Trials Show Ethical Alternatives Are Most Promising

    The California Institute for Regenerative Medicine (CIRM) ended 2015 by adopting a new Strategic Plan, calling it a “bold new vision for the future” designed to streamline, over the next five years, the process of bringing stem cell research to clinical trial.

    Dubbed “CIRM 2.0” the plan is characterized as “a radical overhaul” of business as usual in order to achieve CIRM’s mission to “accelerate the development of stem cell therapies to patients with unmet medical needs.”

    According to Jonathon Thomas, CIRM’s chair of the board, the first step in developing the new plan was “us throwing out all our preconceived notions.”

  • Written Testimony of David A. Prentice, Ph.D.: Update on Progress of Kansas’ Midwest Stem Cell Therapy Center Research

    In this testimony before multiple Kansas state Senate and House committees, Dr. David Prentice briefs legislators on the progress of the Midwest Stem Cell Therapy Center. The Kansas stem cell center is focused on patients, with an emphasis on therapy, dissemination of information, and comprehensive view to fulfilling its mission. The MSCTC only works with non-controversial stem cell sources—adult stem cells and induced pluripotent stem (iPS) cells; embryonic and fetal sources are not used, in keeping the focus on the patient and deliverable therapies.

  • New Video: Child with High Risk Leukemia Recovers after Adult Stem Cell Transplant

    Today the Charlotte Lozier Institute released its newest Stem Cell Research Facts video telling the story of 10-year-old Devon Weaver of Arizona. For many years, Devon’s parents and doctors were mystified as to why he struggled with everyday activities such as sitting up by himself and feeding himself, and why at four years old his bone density was that of a two-year-old. Finally, when Devon was eight, he was diagnosed with Juvenile Myelomonocytic Leukemia (JMML) – a high-risk leukemia with a slim survival rate of 5 to 10 percent in children.

  • Time to End Embryo-Destroying Stem Cell Research

    Will induced pluripotent stem cells (iPSCs) finally replace human embryonic stem cells (hESCs) in the field of regenerative medical research?

    Results of a recent study published in Nature Biotechnology argue that they should.

    First, some background.

    In 2007, Japanese scientist Shinya Yamanaka discovered a method to create fully pluripotent, embryonic-like stem cells from ordinary somatic (body) cells. The ability to do this had been characterized as the “holy grail” of stem cell research and, indeed, Yamanaka’s achievement changed the field of regenerative medicine. So groundbreaking was his discovery that he was awarded the Nobel Prize just five years after announcing it.

  • Stem Cell Awareness Day: Major Research Center’s Quest for Cures Uses Ethical Sources Only

    Recently, numerous research facilities, both public and private, marked “Stem Cell Awareness Day,” holding lectures, issuing statements and highlighting ongoing progress in the field of regenerative medicine.

    Among those participating was the University of California, Davis, one of the country’s leading institutions for stem cell research and regenerative medicine. Writing in her local newspaper, the Davis Enterprise, Jan Nolta, the director of the Stem Cell Program at the UC Davis School of Medicine, highlighted the program’s “numerous novel clinical trials ongoing and in the pipeline” and its 16 disease teams testing stem cells to treat the following…

  • New Video Celebrates Patient’s Recovery from Blood Cancer after Adult Stem Cell Transplant

    On Monday, the Charlotte Lozier Institute released a new video which tells the story of 67-year-old Bill Bourland, who was diagnosed with a life-threatening blood cancer called Myelodysplastic Syndromes (MDS). Thanks to his wife’s determination, a fortuitous meeting with a neighbor, a doctor experienced with adult stem cell treatment, and the generosity of his brother, Bill has received a second chance at life with a clean bill of health.

  • Clarifying a White House Letter on Stem Cell Research

    The White House recently launched a site on Tumblr to feature letters sent to the president by the American people.

    The handful of letters posted so far cover a variety of subjects, including the usual suspects such as jobs, wages, healthcare and the economy.

    But one letter in particular stands out and has garnered attention in the media — including media overseas e.g., here and here.

    The letter is from 15-year-old Gavin Nore of Iowa. Early in 2013, Gavin was diagnosed with Hodgkin’s lymphoma. Gavin courageously fought back against his diagnosis. Doctors utilized stem cells to treat Gavin and this treatment, combined with Gavin’s bravery, led to victory in his battle against this cancer.

  • Stem Cell Research: Predictions, Predilections and Progress

    A recent blog posted on the science/technology website Gizmodo conducts an interesting thought experiment. The author goes back 10 years to the December, 2005, issue of Scientific American. In that issue was the “Scientific American 50” – a list of the 50 leading scientific trends for that year.

    The author wanted to see what has happened, 10 years on, in realizing “the highly-touted breakthroughs of the era that would supposedly change everything.” The author writes that she chose 2005 “because 10 years seemed recent enough for continuity between scientific questions then and now but also long enough ago for actual progress. More importantly, I chose Scientific American because the magazine publishes sober assessments of science, often by scientists themselves.”

  • Charlotte Lozier Institute Presents First Video on Life-Saving Adult Stem Cell Success

    Today, the Charlotte Lozier Institute (CLI) presents its first-ever video celebrating one account of a life-saving ethical adult stem cell treatment.

    The short video recounts the poignant story of Paul Wagle, a young man from Kansas who was diagnosed with cancer at age 10 and endured chemotherapy for two-and-a-half years only to then relapse. He was offered adult stem cell treatment, and the rest is history.

  • Written Testimony of David A. Prentice, Ph.D.: Progress on Kansas’ Midwest Stem Cell Therapy Center Research

    In this testimony before multiple Kansas state Senate and House committees, Dr. David Prentice briefs legislators on the progress of the Midwest Stem Cell Therapy Center. There are currently about 53 centers nationwide conducting ethical adult stem cell research for therapies to treat a wide range of diseases and conditions. The Midwest Stem Cell Therapy Center at the University of Kansas is unique, comprehensive, and focused on patients first.

  • Ethical Adult Stem Cell Treatments Result in “Profound Improvement” for MS Patients

    British media are reporting a significant development in the use of ethical, non-embryonic stem cells to treat patients with multiple sclerosis (MS) and, perhaps, other auto-immune diseases.

    Auto-immune diseases are caused by an abnormal immune response which causes the immune system to attack and destroy healthy tissues in a person’s own body. Such diseases include Type 1 diabetes, rheumatoid arthritis, scleroderma and lupus, among many others. While the exact cause is not known, many researchers believe multiple sclerosis occurs when a person’s immune system attacks tissue of the brain and spinal cord, resulting in severe pain, impaired movement and in the most extreme cases, death.

  • Scientific Advances in Stem Cell Research Continue to Make Use of Embryos Outdated and Unnecessary

    Diabetes has long been one of the main diseases for which human embryonic stem cell (embryo-destroying) research, or hESCR, was claimed to hold the greatest promise of curing.

    But for well over a decade now, ethically contentious human embryonic stem cell research (hESCR) has notably failed to live up to all its hype, with promises of miracle cures within “five to 10 years” remaining unfulfilled.

    That remains true today, despite all the renewed hype that accompanied recent reports that researchers had coaxed hESCs into becoming insulin-producing cells.

  • Maryland Joins the Trend for Ethical Stem Cell Research

    This paper continues the investigation of stem cell research funding in the United States by examining the funding patterns at the Maryland Stem Cell Research Commission. This investigation reveals that the Maryland Commission is keeping with the trend of investing more money in ethical stem cell research as opposed to embryonic as it is this route which is providing demonstrable results.

  • Stem Cell Alternative Campaign Progressing in the European Union

    A European grassroots initiative with the bold objective of protecting human life even in its most vulnerable embryonic state has gained considerable support across the continent- collecting over 850,000 signatures from a wide array of nations. The “One of Us” initiative is a valiant effort that has been taken up by groups and individuals across […]

  • New California Grants Once Again Bolster Ethical Stem Cell Alternatives

    The most recent round of grants by the California Institute for Regenerative Medicine (CIRM) demonstrates – again – where the future of stem cell research lies.   As documented in a previous publication on this website, since its first round of grants to specific research projects in 2007, CIRM has been steadily moving away from its […]

  • Major Step Forward for Ethical Stem Cell Research

    A major New England biotech company recently announced that it would begin the process that it hopes will result in the first clinical trial using induced pluripotent stem cells (iPSCs).     This is hardly surprising, as the discovery, by Shinya Yamanaka, of the process to produce embryonic-like, fully pluripotent stem cells from ordinary somatic (body) cells has […]

  • The Ethical Stems of Good Science

    This paper examines the funding pattern of the California Institute for Regenerative Medicine, an institution which characterizes itself as the “largest source of funding for stem cell research outside the NIH.” Tarne demonstrates that funding has moved from grants directed primarily towards embryonic stem cell research toward primarily ethical stem cells research – which has been the only stem cell research to date to result in positive treatments for illnesses.

  • Possible Adult Stem Cell Therapy for Blood-Disorders in Down Syndrome

    A recent study from researchers at the University of Washington announced a major step forward in the treatment of genetic diseases and specifically in treating Down syndrome patients.     Down syndrome occurs when there is an extra copy of chromosome 21 (hence its alternative name, Trisomy 21) in the individual’s genetic makeup, causing the physical and mental […]

  • Dr. Yamanaka’s Nobel Prize a Victory for Ethical Stem Cell Research

    The Nobel Prize for Medicine awarded to Japan’s Shinya Yamanaka last month is a thoroughly deserved recognition of his groundbreaking work in regenerative medicine, work that just five years ago forever changed the way stem cell research is conducted around the globe.     It is also welcome recognition for a man who took seriously the ethical […]

  • The Trend Towards Ethical Stem Cell Success Continues

    Two recent developments involving the California Institute for Regenerative Medicine (CIRM) again serve to underscore the reality that adult and other non-embryonic avenues of stem cell research are advancing at a far more dramatic pace toward providing actual therapeutic benefits for patients than is human embryonic stem cell research (hESCR).

  • Santorum Launches Campaign for Stem Cell Research Institute

    Last week, Former GOP Presidential candidate Rick Santorum returned to Iowa.  This time he was not there to campaign for public office but to instead announce his new position as the official spokesman  for the Give Cures campaign.  The Give Cures campaign is the John Paul II Stem Cell Research Institute’s “national gift campaign that raises funds to advance […]

  • iPSCs: A New Gold Standard in Regenerative Medicine?

    A recent press release from the National Institutes of Health calls attention to a study, published in Stem Cell Reports, that researchers have “developed a clinical-grade stem cell line, which has the potential to accelerate the advance of new medical applications and cell-based therapies for millions of people suffering from such ailments as Alzheimer’s disease, Parkinson’s disease, spinal cord injury, diabetes, and muscular dystrophy.” The development of these clinical grade stem cells, the release notes, “removes a significant barrier in the development of cell-based therapies.” But is NIH’s promotion of “stem cells” anything new?

  • Dr. David Prentice Joins the Charlotte Lozier Institute as VP and Research Director

    WASHINGTON, D.C. – The Charlotte Lozier Institute (CLI), the education and research arm of the Susan B. Anthony List, is pleased to announce today that Dr. David Prentice will join the organization as its Vice President and Research Director. Dr. Prentice brings over three decades of experience in life sciences including stem cells, cloning, cell biology, genetics, biotechnology, bioethics, and life-related research and policymaking.

  • The Science and Politics of Cloning: What the News Was All About

    In this paper, Dr. Maureen Condic of the University of Utah explains the derivation of human stem cells from cloned human embryos. Dr. Condic discuss the science and politics behind cloning and why this method is unlikely to ever be the preferred tool of regenerative medicine.

  • Bibliography

    Abate, Paula, Mariana Pueta, Norman E. Spear, and Juan C. Molina. “Fetal Learning About Ethanol and Later Ethanol Responsiveness: Evidence Against ‘Safe’ Amounts of Prenatal Exposure.” Experimental Biology and Medicine 233, no. 2 (February 1, 2008): 139–54. Abbasi, Soraya, Corrina Oxford, Jeffrey Gerdes, Harish Sehdev, and Jack Ludmir. “Antenatal Corticosteroids Prior to 24 Weeks’ […]

  • Fact Sheet: Fetal Survival and Risk of Pregnancy Loss  

    With advancements in science, non-surgical interventions are available to women that can increase pregnancy health.  A mother’s daily consumption of folic acid and immunization are important proactive steps that every mother can take to decrease the risk of disease for herself and her baby.

  • What you need to know about the COVID-19 vaccines

    Last updated June 2, 2021   Most COVID-19 Vaccines Do Not Use Fetal Cells for Production; Several Used Abortion-Derived Cell Lines in Testing; Experts Urge All Vaccine Developers to Use Noncontroversial Alternatives   View short chart View full chart Charlotte Lozier Institute (CLI) has published a new chart (en español) detailing whether the eight leading […]

  • CLI Responds to Misinformation Regarding President Trump’s COVID-19 Treatment

    A statement from David Prentice, Ph.D., and Tara Sander Lee, Ph.D., of the Charlotte Lozier Institute:   “Uninformed commentary has emerged this morning stating that President Trump has received a medication created with the use of human embryonic stem cells.  CLI has reviewed the published information and our conclusion is straightforward: The president was not […]

  • Federal Bioethics Commissions and Bias Against the Unborn

    This is Issue 17 in The American Reports Series. The paper may be viewed as a PDF here: Federal Bioethics Commissions and Bias Against the Unborn   In August, the Trump administration’s new Human Fetal Tissue Research Ethics Advisory Board reviewed requests made to the National Institutes of Health (NIH) for federally funded fetal tissue […]

  • A Policy and Funding Evaluation Of Human Fetal Tissue Research

    This is Issue 2 in CLI’s On Science. To view this report as a PDF, see: A Policy and Funding Evaluation Of Human Fetal Tissue Research   Background The body parts of preborn babies that die through the act of elective abortion are harvested and sold to desiring scientists for experimentation.  These acts are heinous, […]

  • Pro-Life Topics for Lawmakers Regarding Coronavirus

    This is Issue 43 in CLI’s On Point Series. To view this report as a PDF, see: On Point 43 Pro-Life Topics for Lawmakers Regarding Coronavirus.   Abortion advocates have found a new ally—COVID-19.   During this intensely stressful time, the vast majority of Americans are focused on protecting their health and the health of […]

  • Available Resources from the Charlotte Lozier Institute

    To view this list as a PDF, see: Available from the Charlotte Lozier Institute   Last updated January 21, 2020   Special Websites  This website includes new videos on therapies and cures using ethical sources of stem cells, blogs on current topics, and a search engine for ethical stem cell research trials.  […]

  • Lozier Institute on Gene-Editing: Focus on Helping Patients, Not Creating Designer Babies

    As the scientific community weighs the risks and rewards of CRISPR, a controversial gene-editing tool, scientists in New York City are moving forward with experiments changing DNA on human sperm. In response to these new germline (heritable) experiments and the broader conversation surrounding CRISPR, Charlotte Lozier Institute (CLI), the research and education arm of Susan B. […]

  • Major Pro-life Victory: HHS Cancels Huge Contract for Taxpayer-Funded Experimentation with Body Parts of Aborted Babies, Announces New Approach

    Washington, D.C. – Following news that the U.S. Department of Health and Human Services (HHS) and National Institutes of Health (NIH) will not renew a major contract with the University of California, San Francisco (UCSF) to fund research using the body parts of aborted babies, the national pro-life group Susan B. Anthony List (SBA List) […]

  • Use of Aborted Fetal Tissue: Questions & Answers  

    On May 23, Susan B. Anthony List and Charlotte Lozier Institute hosted a hearing for Capitol Hill staff on the state of fetal issue research. The panel consisted of Drs. David Prentice, Tara Sander Lee, and James Sherley, and was moderated by SBA List’s Autumn Christensen. These are their questions and answers, as provided to […]

  • CLI Scientists Respond to Letter on Genetically Modified Children: Not Enough

    FOR IMMEDIATE RELEASE: March 14, 2019 Contact: Nicole Stacy,, 202-223-8073   Washington, D.C. – Yesterday 18 scientists representing seven countries published a letter calling for a “global moratorium on all clinical uses of human germline editing — that is, changing heritable DNA (in sperm, eggs or embryos) to make genetically modified children.” Charlotte Lozier […]

  • Written Testimony of Tara Sander Lee, Ph.D., in Support of Ethical Alternatives to Aborted Fetal Tissue Research

    On Thursday, December 13, 2018, the U.S. House of Representatives subcommittee on Healthcare, Benefits, and Administrative Rules and Government Operations for the Committee on Oversight and Government Reform held a hearing on “Exploring Alternatives to Fetal Tissue Research.” The hearing was called as the U.S. Department of Health and Human Services re-evaluates funding for research using […]

  • Congress to Hear from Scientific Experts on Ethical Alternatives to Aborted Fetal Tissue Research

    FOR IMMEDIATE RELEASE: December 12, 2018 Contact: Nicole Stacy,, 202-223-8073   New Video Shows that Adult Stem Cells and Other Ethical Alternatives are Delivering Powerful Results for Patients Now Washington, D.C. – A U.S. House of Representatives subcommittee will hold a hearing on “Exploring Alternatives to Fetal Tissue Research” tomorrow, December 13 at […]

  • Minnesota Court Rules in Favor of University’s Use of Aborted Fetal Tissue for Research

        The Minnesota Court of Appeals has ruled in opposition of Pro-life Action Ministries, legally represented by Thomas More Society, which filed a lawsuit in 2016 against the University of Minnesota for its unlawful use of aborted human fetal tissue in research.  Pro-life Action Ministries alleged that the University of Minnesota was procuring and […]

  • Researchers Create First Human-Chicken Hybrid Embryos

      Scientists at New York City’s Rockefeller University recently created the first human-chicken hybrid embryos and used them to identify the presence of a human developmental cell organizer; the creation of the hybrid embryos has caused some to question the ethical implications of grafting embryonic human cells into other species.   Organizer cells have been […]

  • Dr. David Prentice on Embracing Ethical New Technologies

    Some scientists have said one reason they don’t consult bioethicists or think about the ethical implications of their research is because ethicists usually say “no” to new technologies, or that ethics is arbitrary. But what they are really avoiding is the necessity of setting rational limits on science, thinking they can thereby avoid any limits […]

  • Fact Sheet: Responses Regarding Poor Prenatal Diagnosis

    This fact sheet outlines the various responses to a “poor prenatal diagnosis” for a fetal abnormality, noting especially recent medical advances well as the life-affirming option for perinatal hospice.

  • Backgrounder: We Need a New NIH Director

    On April 25, 2017, Charlotte Lozier Institute Vice President and Director of Research, Dr. David A. Prentice, Ph.D., was published in USA Today on the need for a new National Institutes of Health (NIH) Director. The backgrounder below provides summary main points and sources on the position of current NIH Director Dr. Francis Collins in support of human embryonic stem cell research, human cloning, and the creation of ethically-questionable human-animal chimeras.

  • Q&A with the Scholars: Science, Ethics, and Fetal Tissue

    Tara Sander Lee, Ph.D., is a Molecular and Cell Biologist with over 15 years of experience in academic research and healthcare. In this interview, she discusses genetic testing for diagnosis and treatment of children and the ethical and scientific issues surrounding the use of fetal tissue procured from abortion for research.

  • Written Testimony of Tara Sander Lee, Ph.D., in Support of Texas Bill to Prohibit Human Fetal Tissue Research

    On Wednesday, February 15, 2017, the Texas Committee of Health and Human Services held a hearing regarding Texas Senate Bill 8 (SB 8). SB 8 prohibits partial-birth abortions, prohibits donation of human fetal tissue except by certain authorized facilities to accredited universities, and prohibits the purchase or sale of human fetal tissue. Charlotte Lozier Institute Associate Scholar Tara Sander Lee, Ph.D., submitted the following written testimony in support of SB 8.

  • Q&A with the Scholars: Science and the Beginning of Human Life

    Maureen Condic, Ph.D., is an Associate Professor of Neurobiology and Anatomy at the University of Utah. She has been a member of the Pontifical Academy for Life, a distinguished group of physicians, scientists, and theologians from the international community whose mission it is to study questions and issues regarding the promotion and defense of human life from an interdisciplinary perspective, since 2014. In this interview, she discusses the beginning of human life and the moral status of the human being.

  • Next Station Stop: The Embryo Farm?

    One of the earliest attempts to square this circle of trying to conduct morally problematic research within ethical guidelines is the “14-day rule” for embryo research. The rule has allowed embryo research outside the womb for up to 14 days post-fertilization, after which time the embryo would be destroyed. Although the origins of the rule go back over 40 years, it has been much in the news lately as scientists have developed methods to considerably extend the life of embryos outside the womb.

  • James L. Sherley, M.D., Ph.D.

    James L. Sherley graduated from Harvard College in 1980 with a B.A. degree in biology; and he completed joint M.D. and Ph.D. degrees at the Johns Hopkins University School of Medicine in 1988. After post-doctoral studies in cancer cell molecular biology at Princeton University, he joined the Fox Chase Cancer Center as a principal investigator in 1991. In 1998, […]

  • Fox Foundation Funding Patterns Favor Ethical Approaches

    Beginning in the 1990’s, and throughout the first years of the 21st century, perhaps no other political or social cause célèbre attracted as many celebrities as human embryonic stem cell research (hESCR).

    Christopher Reeve, Kevin Kline, Michael J. Fox and Mary Tyler Moore, among others, all made their way to Capitol Hill to testify in support of increased federal funding of hESCR (during her congressional testimony on behalf of the Juvenile Diabetes Foundation, Ms. Moore famously said human embryos have “no more resemblance to a human being than a goldfish”)…

  • Testimony of Dr. David Prentice in Support of Arizona Bill to Prohibit Fetal Tissue Trafficking

    On Wednesday, March 16, 2016, the Arizona House Judiciary Committee panel held a hearing to consider SB 1474, introduced by Sen. Nancy Barto (R-Phoenix) to prohibit fetal tissue trafficking. After the hearing, the panel voted to pass the bill, which will now head to the full House.

    Charlotte Lozier Institute Vice President and Director of Research, Dr. David Prentice, Ph.D. submitted the following written testimony in support of the legislation.

  • CLI Director of Research David Prentice, Ph.D., Becomes Featured Author for Bioethics Quarterly

    The National Catholic Bioethics Quarterly is an invaluable resource not only for insights on ethical issues but news about key developments in medicine and technology. This summer NCBQ added a new author to its array of resources, a regular update on Science written by Charlotte Lozier Institute Vice President and Director of Research, David Prentice, Ph.D.

  • Written Testimony of David A. Prentice, Ph.D. in Support of Wisconsin Bill to Prohibit Sales and Use of Fetal Body Parts from Abortion

    On Tuesday, August 11, 2015, the Wisconsin Committee on Criminal Justice and Public Safety held a public hearing on Assembly Bill 305, which would prohibit certain sales and uses of fetal body parts “from an unborn child aborted from an induced abortion.”

    Charlotte Lozier Institute Vice President and Research Director, Dr. David A. Prentice, Ph.D submitted the following written testimony in support of AB 305.

  • Planned Parenthood’s Fetal Tissue and Organ Harvesting Forces a Reconsideration of Medical Ethics

    Over the past few weeks you have most likely seen – unless you work at the White House – the undercover videos released by David Daleiden and the Center for Medical Progress, which show various Planned Parenthood employees discussing the harvesting and sale of fetal organs and body parts. The negotiations caught on camera suggest that these transactions are not at all unusual for the organization nor are they limited to these few incidences but are, in fact, systemic throughout the organization. This suggests that Planned Parenthood, which performs about 330,000 abortions a year in the United States, has found a way to make abortion even more profitable.

  • David Prentice, Ph.D.

    David A. Prentice is Vice President and Research Director for the Charlotte Lozier Institute.  He is also Adjunct Professor of Molecular Genetics at the John Paul II Institute, The Catholic University of America and was a Founding Advisory Board Member for the Midwest Stem Cell Therapy Center, a unique comprehensive stem cell center in Kansas […]

  • Jean Peduzzi-Nelson, Ph.D.

    Dr. Jean Peduzzi-Nelson is an Associate Professor of the Department of Anatomy of Cell Biology at the Wayne State University School of Medicine. The focus of Dr. Peduzzi-Nelson’s work is adult stem cells and their potential in the treatment of brain and spinal cord injuries and radiotherapy-induced brain damage. As an expert on adult stem […]

  • Maureen Condic, Ph.D.

    Dr. Condic is an Associate Professor of Neurobiology at the University of Utah.  Her research focuses on the role of stem cells in development and regeneration, and has been recognized by both the Basil O’Connor and the McKnight awards.  She is currently a member of Pontifical Academy for Life, and in 2018, was appointed by […]

  • Thailand Moves to Reform Law following Surrogacy Cases Gone Awry

    Last week, Thailand officials announced a reform of its surrogacy legislation by way of a newly drafted bill that would ban commercial surrogacy. This move to tighten restrictions comes after two widely-reported and controversial surrogacy cases gone wrong in the nation – the now-famous story of Gammy, a twin abandoned by his intended parents due […]

  • Improving Joyful Lives: Society’s Response to Difference and Disability

    This paper looks at the highly complex genetic condition that is Down syndrome and society’s response to individuals with this condition. This important paper points out that while research to improve the lives of those with Down syndrome has progressed, federal funding for it lags considerably behind that for other genetic disorders. Policy recommendations are made for the support of those with this condition and their families.

  • Cloning is Cloning is Cloning

    This primer on cloning examines the nature and purpose of human cloning in light of recent developments in stem cell technology. The paper points out that all cloning is reproductive and reflects on the immediate outcome of human cloning – a human embryo – while examining the terminology used by cloning advocates to obscure the facts.

  • 15 Facts at 15 Weeks

    This is issue 3 in CLI’s On Science Series. To view this report as a PDF, see: 15 Facts at 15 Weeks     This year, the Supreme Court agreed to hear the case Dobbs v. Jackson Women’s Health Organization, which would allow Mississippi to limit abortions at 15 weeks. Medical advancements have long surpassed […]

  • At Different Times in Life

    As children head back to school, many parents are snapping “first day of school” pictures. This annual event documents not only some interesting fashion trends, but also how physically different we look at different ages.  I recently found an older family album that solidified this fact. I had to take a second look to verify […]

  • ISSCR’s Reversal of the 14-Day Rule

    Society sits on the cusp of some of the few remaining battles threatening to permanently alter the course of bioethical history; if these battles are not engaged, the proposed changes in bioethics will make acceptable atrocities upon human dignity the magnitude of which can only be imagined.

  • Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines

    To view this chart as a PDF, see: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines   Updated June 2, 2021   Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine. One concern regarding the ethical assessment of […]

  • A Visual Aid to Viral Infection and Vaccine Production

    This is Issue 1 in CLI’s On Science. To view this report as a PDF, see: A Visual Aid to Viral Infection and Vaccine Production   Updated November 2020   Introduction As a result of the rapid spread of the new coronavirus technically known as SARS-CoV-2, the United States and other governments have begun crash […]

  • Unique from Day One: Pro-life is Pro-science

    Science displays majesty in Alexander Tsiaras’ “From Conception to Birth Visualization” shared during his 2010 TED Talk.  Through magnificent artistry and scientific genius, Tsiaras’ visualization embodies this year’s March for Life theme – Unique from Day One: Pro-life is Pro-science. The presentation depicts the indisputable science of the beginning of human life through its nine-month […]

  • Q&A with the Scholars: Fetal Brain Development and Pain-Capability

    Katrina Furth, Ph.D., earned her doctorate in neuroscience at Boston University, performing her dissertation research at the National Institutes of Health. Since graduating, she has worked as an adjunct professor at Marymount University in Arlington, Virginia. Dr. Furth enjoys educating scientists and non-scientists alike about brain development and leads seminars and talks about the neuroscience […]

  • Frozen Embryos and the “Disposition Decision”

      “Now, they’re gone. Now, I’m never going to know what those babies are going to grow up to be or anything. That’s how it hurts me.”   Carrianne Mahoney, a woman suffering from polycystic ovarian syndrome, uttered these words in March after she and other patients were notified that a system malfunction at Cleveland’s […]

  • The Future of IVF’s Genetic Testing?

    In opening scenes of the sci-fi thriller Gattaca, the viewer meets a couple who decides to conceive their second child by In Vitro Fertilization (IVF), which has become the “natural” method in this futuristic society. They are told by the scientist who created, screened, and edited the DNA of their embryos, “This child is still […]

  • Written Testimony of Sheila Page, D.O., in Support of Texas Bill to Prohibit Dismemberment Abortions

    On Wednesday, February 15, 2017, the Texas Committee of Health and Human Services held a hearing regarding Texas Senate Bill 415 (SB 415). SB 415 prohibits dismemberment abortions, in which a person, with the purpose of causing the death of an unborn child, dismembers the unborn child and extracts the unborn child one piece at a time from the uterus. Charlotte Lozier Institute Associate Scholar Sheila Page, D.O., submitted the following written testimony in support of SB 415.